A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

NCT00347932 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

957

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bacterial Conjunctivitis

Interventions

DRUG: ISV-403
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated